Invesco’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $309K | Buy |
|
|||||
|
2024
Q2 | $462K | Sell |
|
|||||
|
2024
Q1 | $614K | Buy |
|
|||||
|
2023
Q4 | $87.7K | Sell |
|
|||||
|
2023
Q3 | $281K | Buy |
|
|||||
|
2023
Q2 | $345K | Sell |
|
|||||
|
2023
Q1 | $1.95M | Sell |
|
|||||
|
2022
Q4 | $2.1M | Buy |
|
|||||
|
2022
Q3 | $1.79M | Buy |
|
|||||
|
2022
Q2 | $3M | Buy |
|
|||||
|
2022
Q1 | $3.27M | Sell |
|
|||||
|
2021
Q4 | $3.5M | Sell |
|
|||||
|
2021
Q3 | $3.89M | Sell |
|
|||||
|
2021
Q2 | $13.6M | Sell |
|
|||||
|
2021
Q1 | $13.4M | Buy |
|
|||||
|
2020
Q4 | $14.5M | Sell |
|
|||||
|
2020
Q3 | $17.9M | Sell |
|
|||||
|
2020
Q2 | $22.8M | Buy |
|
|||||
|
2020
Q1 | $14.9M | Sell |
|
|||||
|
2019
Q4 | $25.1M | Buy |
|
|||||
|
2019
Q3 | $20M | Sell |
|
|||||
|
2019
Q2 | $22.4M | Buy |
|
|||||
|
2019
Q1 | $13.5M | Sell |
|
|||||
|
2018
Q4 | $11.7M | Sell |
|
|||||
|
2018
Q3 | $38.1M | Buy |
|
|||||
|
2018
Q2 | $32.1M | Buy |
|
|||||
|
2018
Q1 | $21.1M | Sell |
|
|||||
|
2017
Q4 | $23.6M | Sell |
|
|||||
|
2017
Q3 | $28.6M | Buy |
|
|||||
|
2017
Q2 | $35.4M | Buy |
|
|||||
|
2017
Q1 | $13.3M | Buy |
|
|||||
|
2016
Q4 | $12M | Buy |
|
|||||
|
2016
Q3 | $9.77M | Buy |
|
|||||
|
2016
Q2 | $4.22M | Sell |
|
|||||
|
2016
Q1 | $5.34M | Sell |
|
|||||
|
2015
Q4 | $14.8M | Buy |
|
|||||
|
2015
Q3 | $11.9M | Buy |
|
|||||
|
2015
Q2 | $2.82M | Buy |
|
|||||
|
2015
Q1 | $67K | Buy |
|
|||||
|
2014
Q4 | $16K | Buy |
|